Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
News-Medical.Net on MSN
Periodontal bacterial load associated with disease severity in multiple sclerosis
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various associated neurological symptoms, ranging from vision problems to numbness, ...
Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...
New research reveals that when gut bacteria closely resemble the myelin sheath that protects nerve fibers, the immune system can become confused and attack both — accelerating multiple sclerosis.
A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...
Researchers think that by vaccinating kids against mono, they could make multiple sclerosis a disease of the past.
Find out how combined chemical exposures and genetics may raise multiple sclerosis risk in new population research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback